DANNCE.ai
Dannce.ai is revolutionizing neurological drug development and patient care with its AI-powered digital phenotyping platform. By leveraging advanced AI-driven motion analysis, the platform objectively measures neurological conditions, transforming drug trials and clinical decision-making. For clinicians, it offers objective behavioral insights to improve patient assessment and decision-making, while for Pharma & Biotech companies, it provides a more sensitive and objective measure of neurological state, leading to leaner trials and increased probability of detecting efficacy signals. Founded by experts from Duke and Harvard, Dannce.ai has a proven track record across Parkinson's, Autism, and Stroke, aiming to improve patient outcomes and make expert care more accessible.
DANNCE.ai
Dannce.ai is revolutionizing neurological drug development and patient care with its AI-powered digital phenotyping platform. By leveraging advanced AI-driven motion analysis, the platform objectively measures neurological conditions, transforming drug trials and clinical decision-making. For clinicians, it offers objective behavioral insights to improve patient assessment and decision-making, while for Pharma & Biotech companies, it provides a more sensitive and objective measure of neurological state, leading to leaner trials and increased probability of detecting efficacy signals. Founded by experts from Duke and Harvard, Dannce.ai has a proven track record across Parkinson's, Autism, and Stroke, aiming to improve patient outcomes and make expert care more accessible.